Compounds of the form In which Q is selected from -CH=NR12, –W, -CH=2NHR13, –CH=O and -CH(OR17)2 capable of modulating the activity of histone demethylases (HDMEs), which are useful for prevention and/or treatment of diseases in which genomic dysregulation is involved in the pathogenesis, such as e.g. cancer and formulations and methods of use of such compounds.
形式为其中Q从-CH=NR12,-W,-CH=2NHR13,-CH=O和-CH(OR17)2中选择的化合物,能够调节组蛋白去
甲基化酶(H
DMEs)的活性,这些化合物对于预防和/或治疗
基因组失调参与病因学的疾病,例如癌症,以及这些化合物的配方和使用方法是有用的。